NRX Pharmaceuticals, Inc. (NRXP) earnings
Quarterly results of NRX Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
NRX Pharmaceuticals, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) NRX Pharmaceuticals, Inc. reported revenue of $1.1M and a net loss of $16.5M.
Diluted earnings per share were -$0.44.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $1.1M | - | -$16.5M | -$0.44 |
| Q1 FY2026 | $1.1M | - | -$1.4M | -$0.04 |
| Q4 FY2025 | $1.2M | - | $361K | - |
| Q3 FY2025 | $242K | - | -$5.9M | -$0.27 |
| Q2 FY2025 | $0 | - | -$17.6M | -$0.98 |
| Q1 FY2025 | $0 | - | -$5.5M | -$0.34 |
| Q4 FY2024 | - | - | -$9.1M | - |
| Q3 FY2024 | $0 | - | -$1.6M | -$0.15 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is NRX Pharmaceuticals, Inc.'s next earnings date?
NRX Pharmaceuticals, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were NRX Pharmaceuticals, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, NRX Pharmaceuticals, Inc. reported revenue of $1.1M and a net loss of $16.5M. The figures come from its filing with the SEC.
Get an email when NRXP reports
Follow NRXP and we email you its next results the day they are filed, with the numbers explained.